Olivier Christophe
11Patents
1h-index
10Co-inventors
47Inventor score
Filing activity: Dec 21, 2009 → Apr 13, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8436144B2 | Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders | Chemistry; Metallurgy | 6 | Active |
| US8518400B2 | Serine protease derivatives and uses in the prevention or the treatment of blood coagulation disorders | Chemistry; Metallurgy | 1 | Active |
| US10655119B2 | Mutated factor X polypeptides and uses thereof for the treatment of haemophilia | Human Necessities | 1 | Active |
| US11560436B2 | Anti-VWF D'D3 single-domain antibodies fuse to clotting factors | Chemistry; Metallurgy | 0 | Active |
| US8741286B2 | Serene protease derivatives and uses in the prevention or the treatment of blood coagulation disorders | Chemistry; Metallurgy | 0 | Active |
| US10851176B2 | Methods of administering neutralizing anti-protease nexin-1 antibodies to treat hemophilia A | Chemistry; Metallurgy | 0 | Active |
| US10676730B2 | Mutated factor X polypeptides and uses thereof for the treatment of haemophilia | Human Necessities | 0 | Active |
| US10544231B2 | Antibodies for the prevention or the treatment of bleeding episodes | Chemistry; Metallurgy | 0 | Active |
| US11085032B2 | Mutated factor X polypeptides and uses thereof for the treatment of haemophilia | Human Necessities | 0 | Active |
| US10626186B2 | Anti-VWF D'D3 single-domain antibodies and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11597777B2 | Antibodies for the prevention or the treatment of bleeding episodes | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.